NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by May 18, 2025
written by May 18, 2025

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Johnson pushes ‘aggressive’ timetable for House to pass Trump’s budget bill after GOP mutiny: ‘We cannot fail’
next post
Trump wishes Biden ‘fast and successful recovery’ after prostate cancer diagnosis

You may also like

Trump ally stands firm against ‘big, beautiful bill’...

June 8, 2025

Obama WH physician says Biden doc should have...

June 8, 2025

Rubio condemns assassination attempt on Colombian presidential candidate...

June 8, 2025

Trump warns of ‘serious consequences’ if Elon Musk...

June 7, 2025

Musk jokes about reconsidering stance on Big Beautiful...

June 7, 2025

Musk deletes explosive posts about Trump and Epstein...

June 7, 2025

House witness flips script on Dem who ambushed...

June 7, 2025

Trump’s conservative allies warn Congress faces critical ‘test’...

June 7, 2025

Call with China’s Xi, and Trump-Musk exchange fueled...

June 7, 2025

TIMELINE: Inside the evolving relationship between Trump and...

June 7, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Oil and natural gas: Oil is back on the positive side

    • 2

      Gold and Silver: Gold remains stable in the $2420 zone

    • 3

      The dollar index continues to pull back to a new low

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

    Recent Posts

    • Tesla stock sinks as Musk and Trump ridicule each other

      June 8, 2025
    • Trump ally stands firm against ‘big, beautiful bill’ despite pressure: ‘It’ll completely backfire’

      June 8, 2025
    • Rubio condemns assassination attempt on Colombian presidential candidate Miguel Uribe

      June 8, 2025
    • Obama WH physician says Biden doc should have performed cognitive test

      June 8, 2025
    • Trump warns of ‘serious consequences’ if Elon Musk funds Democrats

      June 7, 2025

    Categories

    • Economy (20)
    • Editor's Pick (502)
    • Investing (31)
    • Stock (65)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick